PURE Bioscience, Inc. (OTCMKTS:PURE – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.08 and traded as high as $0.09. PURE Bioscience shares last traded at $0.09, with a volume of 47,925 shares traded.
PURE Bioscience Price Performance
The firm’s 50 day moving average price is $0.07 and its two-hundred day moving average price is $0.08. The stock has a market cap of $10.07 million, a PE ratio of -2.25 and a beta of 0.35.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last released its quarterly earnings data on Monday, March 17th. The company reported ($0.01) earnings per share (EPS) for the quarter. The company had revenue of $0.39 million during the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.
Featured Articles
- Five stocks we like better than PURE Bioscience
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Energy Transfer: Powering Data With Dividends and Diversification
- How to Calculate Inflation Rate
- Qualcomm Stock Is Coiling for a Breakout
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
